Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels

Abstract

Plasma Abeta measures increase with age, but, in contrast to reports on familial AD, plasma Abeta measures were neither sensitive nor specific for the clinical diagnosis of mild cognitive impairment or sporadic AD.